For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240322:nRSV0186Ia&default-theme=true
RNS Number : 0186I Craneware plc 22 March 2024
Craneware plc
("Craneware" or the "Company" or the "Group")
Dividend Currency Election
22 March 2024 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle
solutions for the US healthcare market, today gives further information
regarding its interim dividend announced on 4 March 2024.
For those shareholders who have previously registered to receive their
dividend in US dollars under the Company's Dividend Currency Election, the
dividend will be paid at an exchange rate of $1.27.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications +44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon craneware@almastrategic.com
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Neil Patel, Paul Gillam, Kate Bannatyne
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Cameron MacRitchie
( )
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Dan Gee-Summons
About Craneware
The Craneware Group (AIM:CRW.L), the market leader in automated value cycle
solutions, including 340B management, collaborates with U.S. healthcare
providers to plan, execute, and monitor operational and financial performance
so they can continue to deliver quality care to their communities. Customers
choose The Craneware Group's Trisus data and applications platform as their
key to navigating the journey to financially sustainable value-based care.
Trisus combines revenue integrity, cost management, 340B performance, and
decision enablement into a single, SaaS-based platform. The Craneware Group -
transforming the business of healthcare.
Learn more at www.thecranewaregroup.com (http://www.thecranewaregroup.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DIVJTMITMTBTBJI